The Daily Delta - Canadian AML & Financial Crime News - November 16, 2026
The Daily Delta

The Daily Delta - Canadian AML & Financial Crime News
November 16, 2026

Get The Daily Delta delivered to your inbox each weekday.
Subscribe to The Daily Delta →
Featured
UK National Crime Agency

On November 13, the UK National Crime Agency announced two High Court-approved settlements involving assets worth approximately £55 million linked to a major Singapore money-laundering investigation. The settlements were approved on November 12 following the NCA's use of unexplained wealth orders against the individuals.

Haijin Su, who was convicted in Singapore, agreed to surrender 75% of UK assets worth £35.19 million, including London properties, rental income and bank funds. Haika Xu, who remains wanted by Singaporean authorities, acquired 16 mortgage-free London flats through Rong Hai Development Ltd and Rong Fa Development Ltd, companies of which the NCA identified Xu as the ultimate beneficial owner.

Rather than answer questions under a June 2026 unexplained wealth order about the source of the property funds, Xu settled. The NCA will retain 75% of the property-sale proceeds plus rental income, valued at £19.77 million.

Read more →
Key Developments

Independent AML Effectiveness Reviews
AlphaDelta helps Canadian reporting entities complete required two-year AML effectiveness reviews that are practical, defensible, and aligned to FINTRAC expectations.

Every review includes a 90-day findings clarification session and our 12-month FINTRAC examination support commitment.
Get the weekly recap of the developments shaping AML, sanctions, fraud, and financial crime compliance. Add The Weekly Alpha to your email subscription →
Important Disclosure

The Daily Delta is a curated news briefing produced by AlphaDelta Advisory Group for informational purposes only. It is designed to help readers identify relevant regulatory, enforcement, financial crime, and compliance developments and to direct readers to the original source materials.

Article titles, publisher names, and source links are provided for attribution and reference. Summaries are prepared in AlphaDelta’s own wording, including through the use of automated tools, to provide brief, non-comprehensive descriptions of selected developments. They are not intended to reproduce, replace, or serve as a substitute for the original articles, publications, regulatory guidance, or source materials.

Summaries may omit context, nuance, limitations, author views, subsequent updates, or other information contained in the original source. Readers should review the linked source materials directly before making compliance, legal, operational, policy, or business decisions.

AlphaDelta does not verify, endorse, or guarantee the accuracy, completeness, availability, or timeliness of third-party content referenced in this briefing. All third-party content, trademarks, article titles, publisher names, and related rights remain the property of their respective owners. Reference to third-party materials does not imply endorsement, affiliation, sponsorship, or approval by the original publisher or issuing authority.

If a rights holder believes any reference, summary, or link should be modified or removed, they may contact AlphaDelta Advisory Group at info@alphadeltaadvisory.com for review.
© 2026 AlphaDelta Enterprises Inc. All rights reserved.

When was your last AML effectiveness review?

FINTRAC requires reporting entities to carry out and document an effectiveness review at least every two years.

If your next review is due or approaching, contact AlphaDelta today.
BOOK A REVIEW
© 2026 AlphaDelta Enterprises Inc., operating as AlphaDelta Advisory Group. All rights reserved. Canada.